$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Should Stock Investors Buy and Hold Forever?
07:08pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
The pros and cons of buying a bunch of blue-chip stocks and holding them for 20+ years.
Spero (SPRO) Up Following Positive FDA Update for UTI Drug
02:36pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Spero (SPRO) surges on achieving common ground with the FDA on the regulatory path forward for tebipenem HBr.
Why Novavax Stock Sank to a New 52-Week Low Today
04:35pm, Tuesday, 06'th Sep 2022 The Motley Fool
The vaccine maker's recent regulatory victories aren't landing with investors.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
10:20am, Tuesday, 06'th Sep 2022 Zacks Investment Research
Sector ETF report for XLV
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
05:08pm, Monday, 05'th Sep 2022 Zacks Investment Research
Novavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in Switzerland for adolescents aged 12 to 17 and as a booster in adults aged 18 years and above.
2 Top Trends to Invest $2,000 in Ahead of the Crowd
02:45pm, Monday, 05'th Sep 2022 The Motley Fool
These two trends on the frontier of medicine could present lucrative opportunities for investment.
Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now?
01:00pm, Monday, 05'th Sep 2022 Zacks Investment Research
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
5 Relatively Safe And Cheap Dividend Stocks To Invest In - September 2022
01:30pm, Saturday, 03'rd Sep 2022 Seeking Alpha
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms.
How To Replace 3M Company In Your Portfolio
09:35am, Saturday, 03'rd Sep 2022 Seeking Alpha
I offer replacements that offer comparable attributes to why investors choose 3M Company. Click here to see the list of potential replacements.
Novavax's (NVAX) COVID-19 Booster Gets CHMP Recommendation
05:45pm, Friday, 02'nd Sep 2022 Zacks Investment Research
The European Medicines Agency's CHMP recommends expanded conditional marketing authorization for Novavax's (NVAX) COVID-19 vaccine as a booster for adults.
Is Veeva Systems Stock a Buy Now?
03:15pm, Friday, 02'nd Sep 2022 The Motley Fool
The cloud-based life sciences CRM provider faces a tough slowdown.
Novo Nordisk (NVO) to Tap Into SCD Space With Forma Acquisition
02:09pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Novo Nordisk (NVO) inks agreement to acquire Forma Therapeutics for $1.1 billion. The company is looking to venture into the sickle cell disease and rare blood disorders space.
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
01:06pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) get positive CHMP opinion for Omicron-targeting bivalent booster.
The Zacks Analyst Blog Highlights Pfizer /BioNTec and Moderna's
11:59am, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer /BioNTec and Moderna are part of The Zacks top Analyst Blog.
Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?
10:20am, Friday, 02'nd Sep 2022 Zacks Investment Research
Smart Beta ETF report for DHS
Sign In
Buy PFE